Smith+Nephew’s CARTIHEAL AGILI-C Cartilage Repair Implant Shows Superior Pain Relief and Function at 5 Years

Recent data from a multicenter, randomized controlled trial reveals that Smith+Nephew’s CARTIHEAL AGILI-C Cartilage Repair Implant offers significantly better pain relief and functional improvements over 5 years compared to standard surgical care. This innovative implant is especially beneficial for patients with damaged cartilage who do not qualify for joint replacement, providing a new treatment option. The implant has received FDA approval and will have a specific CPT code effective January 1, 2027.